Delphinus pursues FDA OK for breast cancer device

01/7/2013 | Detroit Free Press

Delphinus Medical Technologies has submitted an application with the FDA for its SoftVue system, a 3D imaging device that could provide doctors with a safer and more precise alternative to mammograms in diagnosing breast cancer. CEO William Greenway said he hopes the company will get an FDA OK to begin marketing the device during the first half of 2013.

View Full Article in:

Detroit Free Press

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC